Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Keytruda showed modest benefits for people with this difficult-to-treat cancer, and combining Opdivo with Yervoy improved outcomes.
HIV-positive individuals are also diagnosed with cancer at later stages than those without the virus.
Responding to the increasing incidence of liver cancer in the United States
A new systematic review and meta-analysis indicates that hepatitis C is most notably also associated with B-cell non–Hodgkin lymphoma.
There are now five targeted therapies for the most common type of liver cancer.
The trial is part of an effort by the Children’s Oncology Group and others to evaluate treatment regimens for children with cancer.
The drug is still associated with a lower liver cancer rate than Baraclude.
A quick overview of Hep Magazine’s reporting on the 53rd International Liver Congress in Vienna
Curing the virus was associated with a lower risk of liver cancer recurrence.
Do you know your liver cancer risk?
Tenofovir was associated with a lower risk of hepatocellular carcinoma, but this might be related to other factors as well.
Study finds that having more diverse gut bacteria was associated with better response to immunotherapy.
Researchers followed nearly 10,000 people with hepatitis C, some of whom were treated with direct-acting antivirals.
The VA has cured HCV in nearly 100,000 veterans, which will dramatically reduce the development of advanced liver disease and liver cancer.
Being diagnosed with liver cancer at a later stage of the disease was associated with a lower three-year survival rate.
A European study of nearly 19,000 people with HIV also found that curing hep C was not associated with heart disease or non-AIDS cancer.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.